Sign In

Karen Malone

Rare Disease & Biomarker Expert - Pharmaceutical Strategy - Market Assessment

Karen Malone is a professional with over 10 years of industry experience in translational medicine, biomarker expertise, and commercial strategy within the rare disease therapeutics sector.

Her background includes working on various drug modalities and targets, spanning from prototype development to final patient trials, with a focus on new product planning and corporate strategy.

She has held roles such as Business Development Specialist at ProQR Therapeutics, Managing Director at Leiden Analytics, Business Consultant at ProQR Therapeutics, and Senior Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson.

Karen's educational background comprises a Ph.D. in Pathobiology from the University of Southern California and a B.S. in Microbiology with a minor in Economics from Arizona State University College of Liberal Arts and Sciences.

She has a track record of supporting change management, evaluating drug development assets, and utilizing data-driven planning approaches for new products in the rare disease space.

In addition, Karen has contributed to organizations like Good Biomarker Sciences, Centre for Human Drug Research, Crossbeta Biosciences B.V., Cleveland Clinic, and PaineWebber.

Highlights

Prevalence Estimates and Genetic Diversity for Autosomal Dominant ...
May 5 · go.bio.org
[PDF] In Vivo - Biotechnology Innovation Organization | BIO

Related Questions

What are some of the key projects Dr. Malone has worked on at ProQR Therapeutics?
How did Dr. Malone transition from scientific research to business development?
What are Dr. Malone's main responsibilities at Leiden Analytics?
Can you provide examples of therapies Dr. Malone has contributed to?
What inspired Dr. Malone to pursue a career in the biotech/pharma industry?
Karen Malone
Karen Malone, photo 1
Karen Malone, photo 2
Add to my network

Location

The Randstad, Netherlands